Gastroenterology — MCQs

A 39-year-old male presents with chronic knee pain, headache, nausea, epigastric pain, and blurred vision. Over the next 48 hours, his condition progresses to confusion, slowed speech, and a decline in Glasgow Coma Scale score, requiring intubation. He also experiences seizure activity. CT brain shows cerebral edema. Laboratory findings reveal an ammonia level of 652 mmol/L (reference range, < 50 mmol/L), a profound elevation of urine orotic acid, a high plasma glutamine level, and a low arginine level. What is the pattern of inheritance of this disease?

Q667Medium

Dysphagia, which is more for liquids than for solids in a 25-year-old female, strongly suggests which of the following possibilities?

Q668Medium

Ascites with Serum-Ascites Albumin Gradient (SAAG) < 1 g/dL is seen in which of the following conditions?

Q669Medium

A 35-year-old female, an occasional drinker, complains of severe pruritus that becomes more bothersome in the evening. On examination, the patient has icteric sclera. Laboratory tests reveal anti-mitochondrial antibodies. What is the possible diagnosis?

Q670Easy

Primary biliary cirrhosis is positive for which antibody?

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 661: What is the best test to diagnose gastroesophageal reflux disease and quantify acid output?

A. Esophagram
B. Endoscopy
C. Manometry
D. 24-hour pH monitoring (Correct Answer)

Explanation: **Explanation:** **24-hour pH monitoring** is considered the **gold standard** for diagnosing Gastroesophageal Reflux Disease (GERD). Its primary value lies in its ability to provide a definitive objective measurement of esophageal acid exposure. It calculates the **DeMeester Score**, which incorporates parameters like the total time pH is <4, the number of reflux episodes, and the duration of the longest episode. This test is specifically indicated for patients with persistent symptoms despite PPI therapy or those being evaluated for anti-reflux surgery (Nissen Fundoplication). **Why other options are incorrect:** * **Esophagram (Barium Swallow):** While useful for identifying anatomical abnormalities like hiatal hernia or strictures, it has very low sensitivity for diagnosing GERD itself. * **Endoscopy (EGD):** This is the first-line investigation to look for complications (esophagitis, Barrett’s esophagus, or malignancy). However, up to 60-70% of GERD patients have **Non-Erosive Reflux Disease (NERD)**, where the endoscopy appears completely normal. * **Manometry:** This is used to assess esophageal motility (e.g., diagnosing Achalasia) and to locate the Lower Esophageal Sphincter (LES) before placing a pH probe. It does not diagnose or quantify acid reflux. **Clinical Pearls for NEET-PG:** * **First-line investigation:** Upper GI Endoscopy (to rule out "red flags"). * **Gold Standard:** 24-hour ambulatory pH monitoring. * **Bravo pH Monitoring:** A wireless capsule version that allows for longer monitoring (48-96 hours) and is better tolerated by patients. * **Impedance-pH monitoring:** The best test to detect **non-acid (alkaline) reflux**.

Question 662: A 30-year-old lady presents with features of malabsorption and iron deficiency anemia. Duodenal biopsy shows complete villous atrophy. Which of the following antibodies is likely to be present?

A. Antiendomysial antibodies (Correct Answer)
B. Anti-goblet cell antibodies
C. Anti-saccharomyces cerevisiae antibodies
D. Antineutrophil cytoplasmic antibodies

Explanation: The clinical presentation of malabsorption, iron deficiency anemia (IDA), and a duodenal biopsy showing complete villous atrophy is classic for **Celiac Disease** (Gluten-sensitive enteropathy) [1]. **1. Why Antiendomysial antibodies (EMA) is correct:** Celiac disease is an immune-mediated enteropathy triggered by gluten ingestion in genetically predisposed individuals (HLA-DQ2/DQ8). **Anti-tissue transglutaminase (tTG) IgA** is the preferred screening test due to high sensitivity, but **IgA Antiendomysial antibody (EMA)** is highly specific (nearly 100%) and is used to confirm the diagnosis. These antibodies target the connective tissue covering of muscle fibers [1]. **2. Why the other options are incorrect:** * **Anti-goblet cell antibodies:** These are associated with **Ulcerative Colitis**, not malabsorption syndromes like Celiac disease. * **Anti-Saccharomyces cerevisiae antibodies (ASCA):** These are markers for **Crohn’s Disease**. While Crohn’s can cause malabsorption, it typically presents with skip lesions and non-caseating granulomas rather than diffuse villous atrophy. * **Antineutrophil cytoplasmic antibodies (p-ANCA):** These are primarily associated with **Ulcerative Colitis** and Primary Sclerosing Cholangitis (PSC). **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** D2 (distal duodenal) biopsy showing Marsh criteria (villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes) [1]. * **Dermatological Association:** Dermatitis herpetiformis (itchy vesicles on elbows/knees). * **Associated Malignancy:** Enteropathy-associated T-cell lymphoma (EATL). * **Initial Screening:** IgA anti-tTG is the best initial test; however, always check total IgA levels to rule out selective IgA deficiency, which is common in these patients [2].

Question 663: Anemia in Wilson disease is due to which of the following reasons?

A. Blood loss anemia due to small superficial ulcerations all over the gastrointestinal tract
B. Hemolysis due to the large amount of copper released into the bloodstream (Correct Answer)
C. Copper-induced bone marrow suppression
D. Relative deficiency of iron in serum due to low ceruloplasmin

Explanation: **Explanation:** The correct answer is **B. Hemolysis due to the large amount of copper released into the bloodstream.** In Wilson disease (Hepatolenticular degeneration), a mutation in the *ATP7B* gene leads to impaired biliary copper excretion [1]. While copper primarily accumulates in the liver and brain, acute hepatic necrosis or sudden release from overloaded hepatocytes can cause a massive spike in free serum copper levels [1]. This excess copper acts as a direct oxidant to erythrocytes, damaging hemoglobin and cell membranes, leading to **Coombs-negative hemolytic anemia**. This is often a presenting feature of "Fulminant Wilsonian Hepatitis" [1]. **Analysis of Incorrect Options:** * **Option A:** Wilson disease does not typically cause diffuse GI ulcerations. While portal hypertension (secondary to cirrhosis) can cause variceal bleeding, it is not the primary mechanism of anemia described in the pathology of the disease [1]. * **Option B:** Copper is toxic to red blood cells but does not cause generalized bone marrow suppression. * **Option D:** Ceruloplasmin is a ferroxidase that helps mobilize iron; however, its deficiency in Wilson disease does not lead to a clinically significant "relative iron deficiency" that explains the acute anemia seen in these patients [2]. **NEET-PG High-Yield Pearls:** * **Coombs Test:** The hemolysis in Wilson disease is characteristically **Coombs-negative**. * **Diagnostic Triad:** Low serum ceruloplasmin, increased urinary copper excretion, and the presence of **Kayser-Ferischer (KF) rings** on slit-lamp exam [1]. * **Liver Biopsy:** The gold standard for diagnosis (showing >250 μg/g dry weight of copper). * **Treatment:** Penicillamine or Trientine (chelators) and Zinc (prevents absorption) [1].

Question 664: Which of the following factors contribute to the development of duodenal ulcers?

A. Gastric acid, Alcohol abuse, Smoking (Correct Answer)
B. Gastric acid, Alcohol abuse
C. Lysolecithin, Prostaglandins, Alcohol abuse
D. Lysolecithin, Prostaglandins, Smoking

Explanation: ### Explanation The pathogenesis of duodenal ulcers (DU) involves an imbalance between **aggressive factors** (which damage the mucosa) and **protective factors** (which maintain mucosal integrity). **1. Why Option A is Correct:** * **Gastric Acid:** Hypersecretion of gastric acid is a hallmark of duodenal ulcers [1]. Increased acid load in the duodenum overwhelms the buffering capacity of the bicarbonate layer, leading to mucosal erosion [1]. * **Alcohol Abuse:** Alcohol is a direct mucosal irritant [2]. It stimulates gastric acid secretion and disrupts the gastric mucosal barrier, making the duodenum more susceptible to acid-pepsin injury [2]. * **Smoking:** This is a major risk factor for Peptic Ulcer Disease (PUD). Smoking increases gastric acid secretion, reduces duodenal bicarbonate production, impairs mucosal blood flow, and inhibits ulcer healing. **2. Why Other Options are Incorrect:** * **Options C and D (Lysolecithin & Prostaglandins):** These are incorrect because **Prostaglandins** are actually **protective factors**. They stimulate mucus and bicarbonate secretion and maintain mucosal blood flow. **Lysolecithin** (produced by bile reflux) is more commonly associated with the pathogenesis of **gastric ulcers** rather than duodenal ulcers [2]. * **Option B:** While correct, it is incomplete as it omits smoking, which is a statistically significant and high-yield risk factor for DU development and recurrence. **Clinical Pearls for NEET-PG:** * **H. pylori:** The most common cause of duodenal ulcers (>90% of cases) [1]. * **NSAIDs:** The second most common cause; they inhibit prostaglandin synthesis [2]. * **Zollinger-Ellison Syndrome:** Suspect this in patients with multiple, refractory, or distal duodenal ulcers (due to massive gastrin-induced acid hypersecretion) [1]. * **Blood Group O:** There is a known genetic association between Blood Group O and an increased risk of duodenal ulcers.

Question 665: What is the most common causative agent of traveler's diarrhea?

A. Campylobacter (Correct Answer)
B. Aeromonas
C. Actinobacillus
D. Cryptosporidium

Explanation: **Explanation:** Traveler’s diarrhea (TD) is defined as the passage of three or more unformed stools in 24 hours, typically occurring in individuals traveling from resource-rich to resource-limited regions. **1. Why Campylobacter is the correct answer:** While **Enterotoxigenic *Escherichia coli* (ETEC)** is globally the most common cause of traveler’s diarrhea [1], among the options provided, **Campylobacter** is the most frequent bacterial isolate. In certain geographic regions, particularly **Southeast Asia**, *Campylobacter* species have surpassed ETEC as the leading cause [2]. It typically presents with inflammatory diarrhea (fever, abdominal pain, and occasionally bloody stools) and is a high-yield association for post-infectious Guillain-Barré Syndrome. **2. Why the other options are incorrect:** * **Aeromonas:** This is a gram-negative rod associated with untreated water and seafood. While it can cause aquatic-associated diarrhea, it is a much less common cause of TD compared to *Campylobacter*. * **Actinobacillus:** This organism (now often classified under *Aggregatibacter*) is primarily associated with aggressive periodontitis and endocarditis (HACEK group), not diarrheal illness. * **Cryptosporidium:** This is a protozoan parasite. While it causes significant outbreaks via contaminated water (especially in immunocompromised patients), parasitic causes account for <10% of TD cases, making it less common than bacterial pathogens [2]. **Clinical Pearls for NEET-PG:** * **Most common cause overall:** ETEC (Enterotoxigenic *E. coli*) [1]. * **Most common cause in Southeast Asia:** *Campylobacter*. * **Drug of choice (Empiric):** Azithromycin is preferred (especially in areas with high *Campylobacter* resistance to Fluoroquinolones). * **Prophylaxis:** Generally not recommended, but Rifaximin may be used in high-risk patients.

Question 666: A 39-year-old male presents with chronic knee pain, headache, nausea, epigastric pain, and blurred vision. Over the next 48 hours, his condition progresses to confusion, slowed speech, and a decline in Glasgow Coma Scale score, requiring intubation. He also experiences seizure activity. CT brain shows cerebral edema. Laboratory findings reveal an ammonia level of 652 mmol/L (reference range, < 50 mmol/L), a profound elevation of urine orotic acid, a high plasma glutamine level, and a low arginine level. What is the pattern of inheritance of this disease?

A. Autosomal dominant
B. Autosomal recessive
C. X-linked disorder (Correct Answer)
D. None of the above

Explanation: The clinical presentation of hyperammonemia, encephalopathy (confusion, seizures, cerebral edema), and specific biochemical markers points toward **Ornithine Transcarbamylase (OTC) Deficiency**, the most common urea cycle disorder [1]. **1. Why the Correct Answer is Right:** The key diagnostic clue is the combination of **hyperammonemia** and **markedly elevated urine orotic acid**. In the urea cycle, when OTC is deficient, carbamoyl phosphate accumulates in the mitochondria and leaks into the cytoplasm. There, it enters the pyrimidine synthesis pathway, leading to the overproduction of orotic acid. * **Inheritance:** Unlike all other urea cycle enzyme deficiencies, which are autosomal recessive, **OTC deficiency is an X-linked recessive disorder**. While it primarily affects males, female carriers can be symptomatic due to skewed X-inactivation (Lyonization) [1]. **2. Why Incorrect Options are Wrong:** * **Autosomal Recessive:** This is the inheritance pattern for other urea cycle disorders like Citrullinemia (Argininosuccinate synthetase deficiency) or Argininosuccinic aciduria [2]. However, these would not typically present with the specific "high orotic acid + low arginine" profile seen here. * **Autosomal Dominant:** Urea cycle disorders are metabolic enzyme deficiencies; these typically require a loss of both alleles (recessive) or are X-linked. They do not follow dominant inheritance patterns. **3. Clinical Pearls for NEET-PG:** * **The "Orotic Acid" Rule:** High Ammonia + High Orotic Acid = OTC Deficiency. High Ammonia + Low Orotic Acid = Carbamoyl Phosphate Synthetase (CPS-1) Deficiency. * **Management:** Acute management involves stopping protein intake, administering IV glucose, and using nitrogen scavengers (Sodium benzoate/phenylacetate). Arginine supplementation is essential (except in Arginase deficiency). * **Triggers:** In adults, symptoms can be triggered by high-protein meals, GI bleeds, or postpartum stress.

Question 667: Dysphagia, which is more for liquids than for solids in a 25-year-old female, strongly suggests which of the following possibilities?

A. Pseudobulbar palsy
B. Achalasia of the esophagus (Correct Answer)
C. Carcinoma of the esophagus
D. Corrosive-induced esophageal stricture

Explanation: ### Explanation **Correct Option: B. Achalasia of the Esophagus** The hallmark of **motility disorders** (like Achalasia) is dysphagia that is either equal for solids and liquids or, characteristically, **more pronounced for liquids** than solids [1]. In a young patient (25 years old), the sudden or progressive onset of this pattern strongly points toward Achalasia. * **Pathophysiology:** It is caused by the failure of the Lower Esophageal Sphincter (LES) to relax and the absence of peristalsis due to the loss of inhibitory neurons (myenteric plexus) in the distal esophagus [1]. Defects in nitric oxide release by inhibitory neurons in the LES have also been reported [1]. **Why the other options are incorrect:** * **A. Pseudobulbar palsy:** While this causes oropharyngeal dysphagia (difficulty initiating a swallow), it typically presents with other neurological signs like "hot potato" voice, emotional lability, and brisk jaw jerk. * **C. Carcinoma of the esophagus:** This is a **mechanical obstruction**. Mechanical blocks typically cause **progressive dysphagia**, starting with solids and only involving liquids in the advanced stages [2]. It is also less common in a 25-year-old. * **D. Corrosive-induced stricture:** Like carcinoma, this is a structural/mechanical narrowing. It leads to progressive dysphagia, primarily for solids initially [2]. **NEET-PG High-Yield Pearls:** 1. **Gold Standard Investigation:** Esophageal **Manometry** (shows incomplete LES relaxation and aperistalsis) [2]. 2. **Barium Swallow Finding:** "Bird’s beak" or "Rat-tail" appearance [1]. 3. **Chagas Disease:** A secondary cause of achalasia caused by *Trypanosoma cruzi*. 4. **Treatment of Choice:** Laparoscopic Heller’s Myotomy (often with Dor/Toupet fundoplication) or POEM (Peroral Endoscopic Myotomy). 5. **Rule of Thumb:** Solids > Liquids = Mechanical (Stricture/Cancer); Liquids ≥ Solids = Motility (Achalasia/DES) [2].

Question 668: Ascites with Serum-Ascites Albumin Gradient (SAAG) < 1 g/dL is seen in which of the following conditions?

A. Cirrhosis
B. Budd-Chiari syndrome
C. Cardiac ascites
D. Nephrotic syndrome (Correct Answer)

Explanation: **Explanation:** The **Serum-Ascites Albumin Gradient (SAAG)** is the most reliable tool for classifying ascites, replacing the old "transudate vs. exudate" terminology [1]. It is calculated as: *SAAG = (Serum Albumin) – (Ascitic Fluid Albumin)* **1. Why Nephrotic Syndrome is Correct:** A **SAAG < 1.1 g/dL** indicates that there is **no portal hypertension** [1]. In Nephrotic Syndrome, ascites develops due to severe hypoalbuminemia, which lowers plasma oncotic pressure. Since both serum and ascitic albumin levels are low, the gradient between them remains narrow (< 1.1 g/dL). Other causes of low SAAG include peritoneal malignancy, tuberculosis, and pancreatitis [1]. **2. Why the Other Options are Incorrect:** * **Cirrhosis (A):** This is the classic cause of **high SAAG (≥ 1.1 g/dL)** [1]. Sinusoidal portal hypertension forces fluid out of the vessels while retaining albumin within the vasculature, creating a wide gradient. * **Budd-Chiari Syndrome (B):** This involves post-sinusoidal portal hypertension due to hepatic vein obstruction. It characteristically presents with a **high SAAG (≥ 1.1 g/dL)** [1] and high ascitic protein. * **Cardiac Ascites (C):** Right-sided heart failure leads to increased systemic venous pressure transmitted to the liver. This results in a **high SAAG (≥ 1.1 g/dL)**, typically accompanied by a high ascitic fluid total protein (> 2.5 g/dL) [1]. **High-Yield Clinical Pearls for NEET-PG:** * **SAAG ≥ 1.1 g/dL:** Indicates Portal Hypertension (Cirrhosis, Cardiac failure, Budd-Chiari, Portal vein thrombosis) [1]. * **SAAG < 1.1 g/dL:** Indicates Non-Portal Hypertension (Malignancy, TB, Nephrotic syndrome, Pancreatitis) [1]. * **Ascitic Protein Trick:** In high SAAG cases, if protein is **< 2.5 g/dL**, think Cirrhosis; if **> 2.5 g/dL**, think Cardiac Ascites or early Budd-Chiari [1].

Question 669: A 35-year-old female, an occasional drinker, complains of severe pruritus that becomes more bothersome in the evening. On examination, the patient has icteric sclera. Laboratory tests reveal anti-mitochondrial antibodies. What is the possible diagnosis?

A. Primary sclerosing cholangitis
B. Xanthogranulomatous cholecystitis
C. Primary biliary cirrhosis (Correct Answer)
D. Alcoholic cirrhosis

Explanation: ### Explanation The clinical presentation and laboratory findings point directly to **Primary Biliary Cholangitis (PBC)**, formerly known as Primary Biliary Cirrhosis. **1. Why the Correct Answer is Right:** * **Demographics:** PBC typically affects middle-aged women (9:1 female-to-male ratio). * **Clinical Features:** The hallmark initial symptom is **pruritus** (often worse at night), which frequently precedes jaundice. * **Pathognomonic Marker:** The presence of **Anti-Mitochondrial Antibodies (AMA)** is the most specific diagnostic marker for PBC (seen in >95% of cases). It is an autoimmune destruction of the small intrahepatic bile ducts, leading to cholestasis. **2. Why Incorrect Options are Wrong:** * **Primary Sclerosing Cholangitis (PSC):** Primarily affects males and is strongly associated with **Ulcerative Colitis**. The characteristic imaging finding is a "beaded appearance" of bile ducts on MRCP. It is associated with **p-ANCA**, not AMA. * **Xanthogranulomatous Cholecystitis:** A rare variant of chronic cholecystitis characterized by lipid-laden macrophages in the gallbladder wall. It presents as gallbladder mass/inflammation, not systemic pruritus with positive AMA. * **Alcoholic Cirrhosis:** While the patient is an "occasional drinker," this does not explain the positive AMA or the specific presentation of pruritus-first cholestasis. Alcoholic liver disease typically shows an AST:ALT ratio > 2:1 and a history of heavy consumption. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for PBC:** The **"M"** Rule: **M**iddle-aged women, **M**itochondrial antibodies (AMA), Ig**M** elevation, and **M**icroscopic bile duct destruction. * **Treatment of Choice:** **Ursodeoxycholic acid (UDCA)** slows disease progression. For pruritus, **Cholestyramine** is the first-line symptomatic treatment. * **Associated Conditions:** Often associated with other autoimmune diseases like Sjögren’s syndrome, Hashimoto’s thyroiditis, and Scleroderma (CREST).

Question 670: Primary biliary cirrhosis is positive for which antibody?

A. P-ANCA
B. Anti-mitochondrial antibody (Correct Answer)
C. Anti-nuclear antibody
D. Anti-microsomal antibody

Explanation: **Explanation:** **Primary Biliary Cholangitis (PBC)**, formerly known as Primary Biliary Cirrhosis, is a chronic autoimmune cholestatic liver disease characterized by the T-cell mediated destruction of small intrahepatic bile ducts [4]. **Why Anti-mitochondrial Antibody (AMA) is correct:** AMA is the hallmark of PBC, present in approximately **95% of patients**. It specifically targets the E2 subunit of the **pyruvate dehydrogenase complex (PDC-E2)** located on the inner mitochondrial membrane [1]. Its presence is highly specific and is one of the three diagnostic criteria for PBC (alongside elevated alkaline phosphatase and characteristic liver biopsy findings). **Analysis of Incorrect Options:** * **A. P-ANCA:** This is primarily associated with **Primary Sclerosing Cholangitis (PSC)** and Ulcerative Colitis. Perinuclear antineutrophil cytoplasmic antibodies (ANCA) have been detected in the sera of 60–80% of patients with PSC [3]. While PBC involves small intrahepatic ducts, PSC involves both intra- and extrahepatic ducts and shows a "beaded" appearance on MRCP. * **C. Anti-nuclear antibody (ANA):** While ANA can be positive in about 30-50% of PBC patients, it is non-specific [1]. It is the screening marker of choice for **Autoimmune Hepatitis (AIH)** and Systemic Lupus Erythematosus (SLE). * **D. Anti-microsomal antibody:** These are typically seen in **Hashimoto’s thyroiditis** (Anti-TPO) or **Autoimmune Hepatitis Type 2** (Anti-LKM1). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for PBC:** The **"4 Ms"** – **M**iddle-aged women, **M**itochondrial antibody, **M** IgM (elevated), and **M**ultinucleated giant cells (granulomas on biopsy). * **Clinical Presentation:** Pruritus (often the earliest symptom) and fatigue [2]. * **Treatment:** **Ursodeoxycholic acid (UDCA)** is the first-line treatment to slow disease progression. * **Associated Conditions:** Frequently associated with other autoimmune diseases like Sjögren’s syndrome and Scleroderma (CREST syndrome) [1].

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free